Celltrion, 558,600 Shares Net Bought by Individuals in Last 5 Days... Stock Price 300,500 Won (+0.67%)

As of 12:30 PM on the 11th, Celltrion is trading at 300,500 KRW, up 0.67% from the previous day. The trading volume is 746,286 shares, which is 61.36% of the previous day's volume. Celltrion is known as a protein and biopharmaceutical manufacturing company.

On September 11, Shin Jae-hoon, a researcher at Hanwha Investment & Securities, made an impressive statement: "Celltrion is already leading the biosimilar market and will continue to lead the market based on its brand value." The company's investment points are R&D and performance. R&D is progressing without any setbacks, and the possibility of performance improvement was already confirmed in the second quarter results. The COVID-19 treatment is also expected to have a positive impact on profitability. Accordingly, the opinion to maintain Celltrion as the top pick in the sector was also upheld." He set Celltrion's target price at 450,000 KRW.

Over the past five days, individual investors have net purchased 550,860 shares of Celltrion, while foreigners and institutions have net sold 364,269 shares and 217,308 shares, respectively.

※ Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an article automation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.